Nuclear Cardiology

888-1 N-terminal pro brain natriuretic peptide predicts cardiovascular events in patients with hypertension and left ventricular hypertrophy: A LIFE study

Treatment Outcome / Risk assessment / Heart Failure / Stroke / Humans / Kidney / Hypertension / Female / Male / Regression Analysis / Follow-up studies / Risk factors / Patient Admission / Left Ventricular Dysfunction / Clinical Sciences / Aged / Middle Aged / Myocardial Infarction / Adult / Nuclear Cardiology / Public health systems and services research / Group / Prognosis / Circulation / Left ventricular hypertrophy / Cardiovascular Diseases / Biological markers / Disease Progression / Risk Factors / Risk Assessment / Myocardial Perfusion Imaging / Losartan / Coronary Artery Disease / Ejection Fraction / Hospital Mortality / Chronic Kidney Failure / Proportional Hazards Models / Predictive value of tests / Life tables / Brain Natriuretic Peptide / Renal Dialysis / Atenolol / Kidney / Hypertension / Female / Male / Regression Analysis / Follow-up studies / Risk factors / Patient Admission / Left Ventricular Dysfunction / Clinical Sciences / Aged / Middle Aged / Myocardial Infarction / Adult / Nuclear Cardiology / Public health systems and services research / Group / Prognosis / Circulation / Left ventricular hypertrophy / Cardiovascular Diseases / Biological markers / Disease Progression / Risk Factors / Risk Assessment / Myocardial Perfusion Imaging / Losartan / Coronary Artery Disease / Ejection Fraction / Hospital Mortality / Chronic Kidney Failure / Proportional Hazards Models / Predictive value of tests / Life tables / Brain Natriuretic Peptide / Renal Dialysis / Atenolol